Botox for Treatment of TMJ Disorder With Bruxism

NCT02202070 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding

Conditions

Temporomandibular Joint Disorders
Bruxism
Temporomandibular Joint Dysfunction Syndrome
Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint

Interventions

DRUG: onabotulinumtoxinA

Sponsor

Washington University School of Medicine